The best-selling drugs of the next 5 years - Pharma Excipients
4.5 (486) · $ 13.00 · In stock
Merck & Co’s immuno-oncology drug Keytruda (pembrolizumab) is projected to be the best-selling drug by annual revenue in 2023, earning $22.2 billion
Merck & Co’s immuno-oncology drug Keytruda (pembrolizumab) is projected to be the best-selling drug by annual revenue in 2023, earning $22.2 billion by 2025, according to new research by GlobalData.Article by pharmaphorum.comThe data forecasts th
Five companies personalizing treatments with 3D printed drugs
World's Top Selling Pharmaceutical Drugs and Manufacturers by Sales
The top 20 drugs by 2021 sales
Decades of Change for the Top Pharmaceutical Companies
Top pharma products by global sales 2022
Top 10 Pharmaceutical Companies 2018 - pharma excipients
Pharmaceutical Excipients Market Size, Share, Trends and Revenue Forecast [Latest]
Top 15 Best-Selling Drugs of 2018: Sales for most treatments grow year-over- year despite concerns over rising prices: GEN Edge: Vol 1, No 1
Top 10 most anticipated drug launches of 2023
Top drugs by sales in 2016: Who sold the blockbuster drugs? - pharma excipients
Pharmaceutical Excipients Market Size, Share, Trends and Revenue Forecast [Latest]
20 Best Selling Drugs 2018
The top 20 drugs by 2021 sales
